Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00744796 · ClinicalTrials.gov registry record
Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
A clinical trial of Corneal Edema Secondary to Corneal Endothelial Dystrophy, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT00744796: Completed study of Corneal Edema Secondary to Corneal Endothelial Dystrophy, sponsored by University of Texas Southwestern Medical Center.
NCT00744796 is a study of Corneal Edema Secondary to Corneal Endothelial Dystrophy that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00744796, a study of Corneal Edema Secondary to Corneal Endothelial Dystrophy, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging modalities available for the anterior segment.
Primary Outcome
Best spectacle corrected visual acuity determined using detection of hand motion, counting of displayed fingers and accuracy of Snellen chart reading at specified distances.
Conditions Studied
Interventions
- PROCEDURE DSAEK
- DIAGNOSTIC_TEST Anterior Segment Optical Coherence Topography (OCT)
- DIAGNOSTIC_TEST Best Spectacle Corrected Visual Acuity (BSCVA)
Study Locations (1)
Texas
- UT Southwestern Medical Center - Aston Ambulatory Clinic - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-07 |
What the finished NCT00744796 record still lists
NCT00744796 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 1 condition, with Corneal Edema Secondary to Corneal Endothelial Dystrophy appearing as the primary indexed condition, and to 3 interventions - of which DSAEK is the first listed.
NCT00744796 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00744796 about?
NCT00744796 is a clinical study titled "Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty". The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging mod...
What is the current status of trial NCT00744796?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2006-12. Estimated completion is 2009-07.
What conditions does trial NCT00744796 study?
This clinical trial studies the following conditions: Corneal Edema Secondary to Corneal Endothelial Dystrophy.
What interventions are being tested in trial NCT00744796?
The interventions under investigation include: DSAEK (PROCEDURE), Anterior Segment Optical Coherence Topography (OCT) (DIAGNOSTIC_TEST), Best Spectacle Corrected Visual Acuity (BSCVA) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00744796?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00744796 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia